ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
13.38
-0.29 (-2.12%)
Mar 21, 2025, 4:00 PM EST - Market closed
ClearPoint Neuro Employees
ClearPoint Neuro had 115 employees as of December 31, 2024. The number of employees increased by 8 or 7.48% compared to the previous year.
Employees
115
Change (1Y)
8
Growth (1Y)
7.48%
Revenue / Employee
$272,957
Profits / Employee
-$164,470
Market Cap
369.72M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CLPT News
- 24 days ago - ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen - Seeking Alpha
- 25 days ago - ClearPoint Neuro, Inc. (CLPT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results - Accesswire
- 5 weeks ago - ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025 - Accesswire
- 5 weeks ago - ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula - Accesswire
- 7 weeks ago - ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0 - Accesswire
- 4 months ago - ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain - Accesswire
- 4 months ago - ClearPoint Neuro: Near-Term Volatility Is No Concern - Seeking Alpha